Medical devices, healthcare technology and the business of care
510(k) clearance · K260656

Carescape ONE; Carescape Dock F0; TruSignal ECG MM; TruSignal PRES MM; TruSignal TEMP MM; TruSignal SpO2 MM 1.8M; TruSignal SpO2 MM 3.0M

GE Healthcare Finland Oy · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONK260656

What did the FDA decide?

FDA recorded a substantially equivalent decision for K260656 on September 1, 2026, with GE Healthcare Finland Oy as applicant. The submission covers Carescape ONE with Carescape Software version 4.0, Carescape Dock F0, and five TruSignal micro-modules: ECG, PRES, TEMP, and SpO2 in 1.8M and 3.0M cable lengths. The micro-modules connect through medical-grade USB ports, each dedicated to one vital sign. The primary regulation is 21 CFR 870.1025 under product code MHX, with additional product codes listed in the summary.

The summary describes Carescape ONE as a bedside monitor usable during intrahospital transport, operating standalone or as an accessory to a compatible host monitor. The dock supplies DC power, charges the battery, and provides host communication. The summary states the dock and micro-modules are not intended for use within a controlled MR environment. The record does not include the decision statement text, performance testing results, or a comparison to a predicate device, so the basis for the equivalence finding is not established here. Substantial equivalence is a clearance, not a PMA approval.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 1, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260656
Regulatory pathway
510(k) premarket notification
Product code
MHX
Decision code
SESE
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).

Product code
MHX
FDA device class
2

FDA decision timeline

  1. K260656 received

    Application receipt date recorded by FDA.

  2. K260656 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MHX

Product / regulatory recordCompanyPathwayDecision dateSource
Ge Medical Systems Information Technologies, Inc.510(k) clearanceNov 3, 2026FDA
Masimo Corporation510(k) clearanceOct 14, 2026FDA
GE Healthcare Finland Oy510(k) clearanceAug 28, 2026FDA
Draeger Medical Systems, Inc.510(k) clearanceAug 20, 2026FDA
Edan Instruments, Inc.510(k) clearanceAug 6, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GE Healthcare Finland Oy

Headquarters
Not reported
Brand website
gehealthcare.com
FDA applicant address
Helsinki

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records